Scottish investment firm Kelvin Capital celebrates record year

Glasgow based investment firm reaches a key milestone by completing its biggest investment yet. Some £10.5 million was invested across nine businesses in Kelvin Capital’s portfolio, which covers sectors like internet and app technology, biotech, life sciences, electronic manufacturing and medical technologies, in 2018. The company has now entered its 10th year having secured £30.2m – made up from its syndicate members’ money, plus co-investment...

Life science businesses secure record equity investment as industry’s stellar growth continues

Scotland’s life sciences companies raised a record £85 million of equity investment during the past year, including a surge in international venture capital support, according to new figures released by Life Sciences Scotland ahead of the industry’s annual awards ceremony. The landmark figure represents a 27% rise on the £67m investment made during the previous 12 months. Companies that have secured funding in the past year include...

£250K Grant to Fund ‘Game-changing’ Immunotherapy Research for Prostate Cancer

Researchers from the University of Glasgow have received a grant worth over £250,000 from health charity, Prostate Cancer UK, to explore an innovative immunotherapy treatment designed to help patients with advanced prostate cancer. The grants have been awarded as part of the charity’s £3 million Research Innovation Awards scheme following a competitive process and detailed assessment from international experts. The scheme encourages researchers across the UK...

Take on the biggest healthcare challenges: apply for funding

UK businesses can apply for a share of up to £10 million to develop technologies, products and processes that could offer better outcomes for patients. The Biomedical Catalyst supports UK businesses to test and develop innovative technologies for healthcare. New healthcare technologies, products and processes could transform the life sciences sector and improve the lives of patients. Through the Biomedical Catalyst – a partnership between Innovate UK...

GSK invests in Montrose

First Minister opens £54 million building. GSK’s £54 million new state-of-the-art production building in Montrose has been opened by First Minister Nicola Sturgeon. Active pharmaceutical ingredients (APIs) for use in GSK’s Ellipta respiratory inhalers will be produced in the building and it is the second multi-million investment on the Montrose site over the last two years. The First Minister said: “This new facility is testament...

Rugby star’s pledge aids bid for MND therapies

Scientists are to use lab tests to investigate whether drugs that already treat a range of conditions could help people with motor neurone disease. The initiative could cut years spent waiting for treatments to become available because the drugs being tested are known to be safe. Researchers at the University of Edinburgh have received £250,000 from the My Name’5 Doddie Foundation, launched by former rugby...

Top